R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda
{"title":"一项评估MN-001(替鲁司特)治疗特发性肺纤维化的安全性、耐受性和初步疗效的单中心、随机、安慰剂对照研究","authors":"R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2435","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":131426,"journal":{"name":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of MN-001 (Tipelukast) in Idiopathic Pulmonary Fibrosis\",\"authors\":\"R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2435\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":131426,\"journal\":{\"name\":\"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2435\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B22. EMERGING MANAGEMENT OF FIBROTIC ILDs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a2435","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of MN-001 (Tipelukast) in Idiopathic Pulmonary Fibrosis